You are here: Industry Insights > Retr

News List

HIV and the Antiretroviral Therapy Capsid Inhibitor Lenacapavir David Orchard-Webb
January 07, 2025
HIV is a major worldwide health issue, producing substantial morbidity and mortality.HIV targets the immune system, primarily CD4+ T cells, depleting them and making the body susceptible to opportunistic infections and malignancies.
RetroBrain Announces Strategic Cooperation with Schenker Technologies and a Grant for its Second Product Line “memoreHome” b3cnewswire
September 13, 2021
Hamburg based digital health growth company RetroBrain R&D GmbH (“RetroBrain”) announces initial strategic cooperation with Schenker Technologies, a leading provider of IT and gaming hardware...
Bio-Techne's RNAscope™ Technology Aids in the Retrospective Tissue Diagnosis of COVID-19 in cases with no previous testing for SARS-CoV-2 prnewswire
August 05, 2021
Bio-Techne Corporation (NASDAQ: TECH) today announced that scientists at the U.S. Centers for Disease Control and Prevention (CDC) recently highlighted the importance of fixed tissue analysis for retrospective diagnosis of SARS-CoV-2 infection
Charles River Acquires Retrogenix contractpharma
April 06, 2021
Charles River Laboratories has acquired early-stage contract research organization (CRO) Retrogenix, a provider of specialized bioanalytical services utilizing its proprietary cell microarray technology, for $48 million.
Retrophin Completes Acquisition of Orphan Technologies americanpharmaceuticalreview
November 25, 2020
Retrophin announced the completion of its previously announced acquisition of Orphan Technologies Limited, a privately held, clinical-stage biopharmaceutical company focused on the development of product candidate OT-58 for the treatment of classical ...
Mallinckrodt launches retrospective study for inhaled therapy in COVID-19 pharmatimes
November 12, 2020
Mallinckrodt has launched a retrospective chart review study which will collect real-world data on the use of INOmax (nitric oxide) gas for inhalation therapy in patients with respiratory complications associated with COVID-19.
Retrophin to Acquire Orphan Technologies americanpharmaceuticalreview
October 26, 2020
Retrophin has entered into a definitive agreement to acquire Orphan Technologies, a privately held, clinical-stage biopharmaceutical company focused on the development of product candidate OT-58 for the treatment of classical homocystinuria (HCU).
CaDi introduces Lycofertilic™ - high potency, targeted supplements with algae DHA Omega-3 to provide anti-ageing support for the ovarian reserve and to prepare for egg retrieval and IVF prnasia
October 23, 2020
Cambridge Diagnostic Imaging (CaDi) is launching a new generation of targeted daily supplements, LycofertilicTM for fertility support and LycofertilicTM Prime to prepare for egg retrieval and IVF.
Jacobs to Retrofit AstraZeneca’s Mfg. Facility for COVID-19 Vax contractpharma
June 16, 2020
Will upgrade an existing idle Fill Line in West Chester, OH to support formulation, vial filling, visual inspection and packaging of the COVID-19 vaccine.
The Lancet retracts study linking hydroxychloroquine with deaths pharmatimes
June 08, 2020
The Lancet has issued a statement that a study which indicated that hydroxychloroquine was linked with higher rates of death in COVID-19 patients has been retracted, after three of its authors said they were unable to 'vouch for the veracity of the primar